ES429585A1 - Procedimiento de preparacion de un alcanol superior. - Google Patents
Procedimiento de preparacion de un alcanol superior.Info
- Publication number
- ES429585A1 ES429585A1 ES429585A ES429585A ES429585A1 ES 429585 A1 ES429585 A1 ES 429585A1 ES 429585 A ES429585 A ES 429585A ES 429585 A ES429585 A ES 429585A ES 429585 A1 ES429585 A1 ES 429585A1
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- higher alkanol
- prostate disorders
- alkanol compositions
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000017497 prostate disease Diseases 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4056873A GB1459233A (en) | 1973-08-29 | 1973-08-29 | Medicament containing a higher alkanol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES429585A1 true ES429585A1 (es) | 1976-09-16 |
Family
ID=10415549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES429585A Expired ES429585A1 (es) | 1973-08-29 | 1974-08-27 | Procedimiento de preparacion de un alcanol superior. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4186211A (es) |
| JP (1) | JPS5076220A (es) |
| AR (1) | AR205721A1 (es) |
| BE (1) | BE819296A (es) |
| CA (1) | CA1036940A (es) |
| CH (1) | CH593218A5 (es) |
| DE (1) | DE2440436C3 (es) |
| DK (1) | DK456674A (es) |
| ES (1) | ES429585A1 (es) |
| FI (1) | FI251974A (es) |
| FR (1) | FR2242080B1 (es) |
| GB (1) | GB1459233A (es) |
| IE (1) | IE39671B1 (es) |
| IL (1) | IL45538A (es) |
| NL (1) | NL7411312A (es) |
| NO (1) | NO743077L (es) |
| SE (1) | SE7410889L (es) |
| ZA (1) | ZA745513B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4340628A (en) | 1979-01-25 | 1982-07-20 | Gilbertson John R | Antibacterial agent and method |
| US4209533A (en) | 1979-01-25 | 1980-06-24 | University Of Pittsburgh | Antibacterial agent and method |
| US4372978A (en) | 1979-11-26 | 1983-02-08 | University Of Pittsburgh | Antibacterial agent and method |
| DE3348493C2 (de) * | 1982-05-28 | 1998-09-17 | Eisai Co Ltd | Verwendung von Docosanol zur Behandlung und Prophylaxe von durch Immunmangelerscheinungen verursachten Infektionskrankheiten |
| DE3348500C2 (de) * | 1982-05-28 | 1998-10-22 | Eisai Co Ltd | beta,gamma-Dihydropolyprenylalkoholderivat |
| FR2532845B1 (fr) * | 1982-05-28 | 1988-01-15 | Eisai Co Ltd | Composition pharmaceutique comprenant a titre de principe actif le docosanol |
| IT1213176B (it) * | 1984-06-11 | 1989-12-14 | Milano A | Composizioni e composti per il trattamento dell'adenoma prostatico. |
| US5071879A (en) * | 1989-04-28 | 1991-12-10 | Lidak Pharmaceuticals | Systemic antiviral treatment |
| US5070107A (en) * | 1989-04-28 | 1991-12-03 | Lidak Pharmaceuticals | Systemic antiviral treatment |
| US5166219A (en) * | 1989-11-02 | 1992-11-24 | Lidak Pharmaceuticals | Systemic anti-inflammatory treatment |
| CA2156063C (en) * | 1993-12-13 | 1999-06-29 | David H. Katz | Sucrose ester c-20 to c-28 alcohol formulations |
| US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
| US6440980B1 (en) * | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| US5948822A (en) | 1996-12-17 | 1999-09-07 | Lidak Pharmaceuticals | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols |
| PT102410A (pt) * | 2000-02-03 | 2001-08-30 | Qualitas Lab | Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico |
| WO2003032915A2 (en) * | 2001-10-16 | 2003-04-24 | Avanir Pharmacueticals | Viral inhibition by n-docosanol |
| US7214394B2 (en) * | 2002-05-31 | 2007-05-08 | Archer-Daniels-Midland Company | Policosanol compositions, extraction from novel sources, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3031376A (en) * | 1956-10-11 | 1962-04-24 | Levin | Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same |
| US3226295A (en) * | 1960-02-08 | 1965-12-28 | Carlos C Goetz | Method of making cetyl alcohol emulsions |
| US3646215A (en) * | 1969-11-26 | 1972-02-29 | Commodity Improvements Inc | Heptadecanol for medical purposes |
| US3929869A (en) * | 1972-06-29 | 1975-12-30 | Labaz | Pentanol derivatives |
-
1973
- 1973-08-29 GB GB4056873A patent/GB1459233A/en not_active Expired
-
1974
- 1974-01-01 AR AR255339A patent/AR205721A1/es active
- 1974-08-20 FR FR7428617A patent/FR2242080B1/fr not_active Expired
- 1974-08-22 IE IE1744/74A patent/IE39671B1/xx unknown
- 1974-08-23 DE DE2440436A patent/DE2440436C3/de not_active Expired
- 1974-08-26 NL NL7411312A patent/NL7411312A/xx not_active Application Discontinuation
- 1974-08-26 IL IL45538A patent/IL45538A/xx unknown
- 1974-08-26 CH CH1158774A patent/CH593218A5/xx not_active IP Right Cessation
- 1974-08-27 ES ES429585A patent/ES429585A1/es not_active Expired
- 1974-08-27 CA CA207,936A patent/CA1036940A/en not_active Expired
- 1974-08-28 ZA ZA00745513A patent/ZA745513B/xx unknown
- 1974-08-28 DK DK456674A patent/DK456674A/da not_active Application Discontinuation
- 1974-08-28 BE BE147990A patent/BE819296A/xx not_active IP Right Cessation
- 1974-08-28 NO NO743077A patent/NO743077L/no unknown
- 1974-08-28 SE SE7410889A patent/SE7410889L/xx unknown
- 1974-08-28 FI FI2519/74A patent/FI251974A/fi unknown
- 1974-08-29 JP JP49098448A patent/JPS5076220A/ja active Pending
- 1974-08-30 US US05/502,036 patent/US4186211A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IE39671B1 (en) | 1978-12-06 |
| SE7410889L (es) | 1975-03-03 |
| AR205721A1 (es) | 1976-05-31 |
| BE819296A (fr) | 1974-12-16 |
| DE2440436A1 (de) | 1975-03-06 |
| FR2242080B1 (es) | 1978-07-21 |
| IL45538A (en) | 1978-06-15 |
| ZA745513B (en) | 1975-08-27 |
| IE39671L (en) | 1975-02-28 |
| FI251974A (es) | 1975-03-01 |
| JPS5076220A (es) | 1975-06-21 |
| NO743077L (es) | 1975-03-24 |
| DE2440436C3 (de) | 1982-03-18 |
| AU7277374A (en) | 1976-03-04 |
| CH593218A5 (es) | 1977-11-30 |
| DE2440436B2 (de) | 1981-02-26 |
| US4186211A (en) | 1980-01-29 |
| IL45538A0 (en) | 1974-11-29 |
| FR2242080A1 (es) | 1975-03-28 |
| NL7411312A (nl) | 1975-03-04 |
| GB1459233A (en) | 1976-12-22 |
| DK456674A (es) | 1975-04-28 |
| CA1036940A (en) | 1978-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES429585A1 (es) | Procedimiento de preparacion de un alcanol superior. | |
| MD1367C2 (ro) | Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom. | |
| JPS57146800A (en) | Aromatic heterocyclic esters of steroids, manufacture and pharmaceutical composition containing them | |
| HRP920632A2 (en) | Oral composition for the treatment of inflammatory l deseases | |
| IE40860B1 (en) | Substituted benzamides | |
| IL45200A (en) | 16 ,17 -cyclopentylidenedioxy-9 -fluoro-11 ,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate and anti-inflammatory compositions comprising it | |
| ES433293A1 (es) | Un procedimiento para la preparacion de compuestos arilace-tileno. | |
| ES8707488A1 (es) | Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona | |
| SE7601535L (sv) | Injicerbara antibiotiska kompositioner | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| ES427164A1 (es) | Un procedimiento para la preparacion de un agente para la anastesia espinal. | |
| ES422694A1 (es) | Procedimiento para preparar acetatos. | |
| DE3380166D1 (en) | Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction | |
| ES426040A1 (es) | Procedimiento de preparacion de esteres cicloalquil-alqui- licos de acidos que tienen el esqueleto del eburnano. | |
| GB1281813A (en) | Cycloalkylidenebutanols and their use in perfume compositions | |
| ZA774164B (en) | Novel medicinal composition for the treatment of biliary lithiasis | |
| GB1483650A (en) | Pharmaceutical preparations based on mesterolone | |
| GB1474749A (en) | Pharmaceutical preparations based on cyproterone | |
| FI74003B (fi) | Foerfarande foer framstaellning av en terapeutiskt anvaendbar 5,14-dihydrobens/5,6/isoindolo/2,1-b/isokinolin- 8,13-dion. | |
| IT1252160B (it) | Composizioni farmaceutiche contenenti il peptidoglicano del lactobacillus casei | |
| SE8104657L (sv) | Injicerbara farmaceutiska kompositioner | |
| GB1498857A (en) | Antidepressant composition | |
| ES8504665A1 (es) | Metodo de preparar derivados de p-acilaminofenol | |
| IL74642A (en) | Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient | |
| JPS5170769A (en) | 10*111 jihidoro 33 karubokishishipuroheputajin oyobi sono nn okisaido |